Sustained Glycaemic Control and Preserved Beta‐Cell Function in Newly Diagnosed Type 1 Diabetes Treated With Semaglutide
Diabetes/Metabolism Research and Reviews · 2026-07 · 42 (5)
DOI: 10.1002/dmrr.70191 ↗Kurz gefasst
Leserbrief in der Zeitschrift Diabetes/Metabolism Research and Reviews, online erschienen am 11.06.2026. Verfasst von Massimo Carollo und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Diagnostics and Public Health, University of Verona, Verona, Italy. Die Arbeit nennt 10 Literaturangaben.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Diagnostics and Public Health, University of Verona, Verona, Italy.
- Department of Primary Care, ULSS 1 Dolomiti, Belluno, Italy.
- Diabetes Research Institute, IRCCS San Raffaele Scientific Hospital, Milan, Italy.
- Department of Medicine, University of Padova, Padova, Italy.
ORCID-Profile: Massimo Carollo
Zitieren
APA
Carollo, M., Martinenghi, S., Gallo, A., & Piarulli, F. (2026). Sustained Glycaemic Control and Preserved Beta‐Cell Function in Newly Diagnosed Type 1 Diabetes Treated With Semaglutide. Diabetes/Metabolism Research and Reviews, 42(5). https://doi.org/10.1002/dmrr.70191
Vancouver
Carollo M, Martinenghi S, Gallo A, Piarulli F. Sustained Glycaemic Control and Preserved Beta‐Cell Function in Newly Diagnosed Type 1 Diabetes Treated With Semaglutide. Diabetes/Metabolism Research and Reviews. 2026;42(5). doi:10.1002/dmrr.70191
BibTeX
@article{Carollo2026,
author = {Carollo, Massimo and Martinenghi, Sabina and Gallo, Alessandra and Piarulli, Francesco},
title = {Sustained Glycaemic Control and Preserved Beta‐Cell Function in Newly Diagnosed Type 1 Diabetes Treated With Semaglutide},
journal = {Diabetes/Metabolism Research and Reviews},
year = {2026},
volume = {42},
number = {5},
doi = {10.1002/dmrr.70191}
}
EUVIMED